Options for correcting nephrogenic anemia in a patient with HIV and chronic kidney disease. Case report

Autor: Victor V. Fomin

Publikováno v: Consilium Medicum, Vol 26, Iss 10, Pp 698-703 (2024)

Anemia is a distinctive manifestation of chronic kidney disease (CKD); it occurs already from stage III CKD and is observed in the vast majority of patients with end-stage renal disease. The primary mechanism of renal anemia is a decrease in the prod

Externí odkaz: https://doaj.org/article/4ab5a2f63c6f455c8158f440ba19b2d0

Erythropoietin (EPO) as a Key Regulator of Erythropoiesis, Bone Remodeling and Endothelial Transdifferentiation of Multipotent Mesenchymal Stem Cells (MSCs): Implications in Regenerative Medicine

Autor: Asterios S. Tsiftsoglou

Publikováno v: Cells, Vol 10, Iss 8, p 2140 (2021)

Human erythropoietin (EPO) is an N-linked glycoprotein consisting of 166 aa that is produced in the kidney during the adult life and acts both as a peptide hormone and hematopoietic growth factor (HGF), stimulating bone marrow erythropoiesis. EPO pro

Externí odkaz: https://doaj.org/article/9c8248491e5c4a88a30a09b8f23fecc0

Neural Differentiation of Human Dental Mesenchymal Stem Cells Induced by ATRA and UDP-4: A Comparative Study

Autor: Anastasios E. Koutsoumparis, Anastasia Patsiarika, Anastasia Tsingotjidou, Ioannis Pappas, Asterios S. Tsiftsoglou

Publikováno v: Biomolecules; Volume 12; Issue 2; Pages: 218

Human mesenchymal stem cells (MSC) are multipotent stem cells, which are isolated from various sources. Currently, there is a worldwide interest for dental MSC to be used against neurodegenerative diseases, since they derive from the neural crest and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e40650914ce2093bb876aa64ba852a8
https://pubmed.ncbi.nlm.nih.gov/35204719

Effectivity of Erythropoietin-Alpha between Fixed- and Adjusted-Dose in Chronic Kidney Disease Patients With Anemia on Hemodialysis

Autor: Mida Purwiningtyas, Bayu Dharma Santi, Budi Suprapti, Yulistiani Yulistiani

Publikováno v: Folia Medica Indonesiana; Vol 55, No 4 (2019): December; 306-310
Folia Medica Indonesiana; Vol. 55 No. 4 (2019): December; 306-310
Folia Medica Indonesiana, Vol 55, Iss 4, Pp 306-310 (2021)

Anemia is a common complication in chronic kidney disease (CKD) patient with hemodialysis. The cause of anemia is mainly due to erythropoetin deficiency because the kidneys as a erythropoetin producer are damaged. The most appropriate management of a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a07098a5452dcb7e338bc27218fbca9f
https://doi.org/10.20473/fmi.v55i4.17334

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.